Published September 17, 2020
| Version v1
Patent
Open
ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES
Contributors
Patent applicant:
Description
Antisense polynucleotides and their use in pharmaceutical compositions to induce exon skipping in targeted exons of the gamma sarcoglycan gene are provided, along with methods of preventing or treating dystrophic diseases such as Limb-Girdle Muscular Dystrophy.
Files
US20200291403.pdf
Files
(2.0 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:43eba72766eb370888c25dde9bc1ca52
|
2.0 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 202016886171 A
- Patent number
- US 2020/0291403 A1
- Other
- oai:uchicago.tind.io:9065
Dates
- Patent filed
-
2020-05-28